Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial

This publication has 12 references indexed in Scilit:

• A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model
  Clinical Therapeutics, 2002
• Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge
  Clinical Therapeutics, 2002
• Allergic and immunologic disorders of the eye. Part II: Ocular allergy
  Journal of Allergy and Clinical Immunology, 2000
• Allergic Rhinoconjunctivitis – An Overview
  Acta Ophthalmologica Scandinavica, 2000
• An Evaluation of Onset and Duration of Action of Patanol^® (Olopatadine Hydrochloride Ophthalmic Solution 0.1%) Compared to Claritin^® (Loratadine 10 mg) Tablets in Acute Allergic Conjunctivitis in the Conjunctival Allergen Challenge Model
  Acta Ophthalmologica Scandinavica, 2000
• The Added Benefit of Local Patanol Therapy When Combined with Systemic Claritin for the Inhibition of Ocular Itching in the Conjunctival Antigen Challenge Model*
  Acta Ophthalmologica Scandinavica, 1999
• Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions
  Journal of Allergy and Clinical Immunology, 1999
• Conjunctival Allergen Challenge
  Archives of Ophthalmology (1950), 1990
• Antiallergic activity of H-receptor antagonists assessed by nasal challenge
  Journal of Allergy and Clinical Immunology, 1988
• Histamine in Human Tears
  American Journal of Ophthalmology, 1977